02 · Monthly Pulse
Top signals across five oral health segments, framed for consultant use. Ingredient innovation, whitening regulation, oral microbiome, and the fluoride vs hydroxyapatite debate — updated monthly by Brendan Walsh.
Edition 05 · November 2026
November 2026A randomized, assessor-blinded trial (Scientific Reports, May 2026; 80 implants, 26 patients, five arms over six months) found standard mechanical debridement, with or without chlorhexidine, ozone, or glycine air abrasion, significantly improved pocket depth, bleeding on probing, and plaque index in early peri-implantitis. No adjunct showed a statistically meaningful edge over plain mechanical care.
Consumer search and social signals also inform velocity rating.
CDT code D2991, in effect since 2024, lets dentists bill for chairside hydroxyapatite-regeneration scaffold treatment (Curodont Repair, CrystLCare) on incipient lesions. Separately, as of an April 2026 review, FDA still regulates toothpaste as a cosmetic product and has not approved hydroxyapatite toothpaste for anti-caries claims; that status is unchanged from the prior edition.
Consumer search and social signals also inform velocity rating.
BLIS, the maker of the K12 and M18 probiotic strains, published a June 2026 summary of four new studies. Only one was a human clinical trial, and it measured chemotherapy-related oral mucositis in cancer patients, not caries or gum disease. The other three were in vitro or animal studies; one found BLIS M18 modestly raised biofilm pH in a lab caries model, with no clinical confirmation yet.
Consumer search and social signals also inform velocity rating.
Consumer media coverage questioning charcoal toothpaste continues to circulate widely, but it traces back to the ADA's standing position (insufficient evidence of safety and efficacy, enamel-abrasion concern) rather than any new 2025 or 2026 ADA statement or Seal of Acceptance decision.
Consumer search and social signals also inform velocity rating.
The global oral care market is sized at roughly USD 58.2 billion in 2026, projected to reach USD 95.7 billion by 2036 at a 5.1% CAGR. Toothpaste remains the anchor category at roughly 70% share; whitening, sensitivity, and herbal formats are cited as the premium-mix drivers.
Consumer search and social signals also inform velocity rating.